An EGF receptor-mediated signal attenuates the inhibitory effect of LPA on an adenylate cyclase activity

被引:3
作者
Arimura, S [1 ]
Saito, Y [1 ]
Nakata, H [1 ]
Fukushima, K [1 ]
Nishio, E [1 ]
Watanabe, Y [1 ]
机构
[1] Natl Def Med Coll, Dept Pharmacol, Tokorozawa, Saitama 3598513, Japan
关键词
pertussis toxin; ADP-ribosylation; epidermal growth factor; lysophosphatidic acid; adenylate cyclase; G-protein;
D O I
10.1016/S0024-3205(98)00423-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A tyrosine kinase receptor-mediated and a heterotrimeric G protein-coupled receptor-mediated signals have been shown to evoke distinct intracellular signaling events. There has been increasing evidence that cross-talk exists between a tyrosine kinase receptor-mediated and a heterotrimeric G protein-coupled receptor-mediated signal transduction pathways. In the present study, we have studied effects of EGF receptor activation on activities of inhibitory G protein (Gi). We show that the amounts of Gi/Go ADP-ribosylated by islet-activating protein (IAP) increased by 30-40 % in the membranes of Rat I fibroblast cells pretreated with EGF compared with those without pretreatment. When an effect of lysophosphatidic acid (LPA) stimulation on an adenylate cyclase activity was examined, LPA partly attenuated forskolin-stimulated adenylate cyclase activity via Gi because IAP pretreatment blocked the inhibitory effect of LPA. Pretreatment with EGF reduced the ability of LPA to inhibit the forskolin-stimulated adenylate cyclase activity, while the pretreatment did not have any effects on the forskolin-stimulated activity. Thus, the EGF receptor-mediated signal appears to cause the impairment of Gi function in Rat 1 fibroblast cells.
引用
收藏
页码:1563 / 1570
页数:8
相关论文
共 50 条
[11]   5-hydroxytryptamine1A receptor-mediated effects on adenylate cyclase and nitric oxide synthase activities in rat ventral prostate [J].
Carmena, MJ ;
Camacho, A ;
Solano, RM ;
Montalvo, L ;
Garcia-López, E ;
Arias, A ;
Prieto, JC .
CELLULAR SIGNALLING, 1998, 10 (08) :583-587
[12]   Effect of asphyxia on adenylate cyclase activity in cat brain cortex [J].
Bolekhan, EA ;
Samoilov, MO .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1997, 124 (08) :735-738
[13]   THE CYSTEINE RESIDUE IN THE CARBOXYL-TERMINAL DOMAIN OF THE M2 MUSCARINIC ACETYLCHOLINE-RECEPTOR IS NOT REQUIRED FOR RECEPTOR-MEDIATED INHIBITION OF ADENYLATE-CYCLASE [J].
VANKOPPEN, CJ ;
NATHANSON, NM .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (06) :1873-1877
[14]   Adenylate cyclase-mediated modulation of interaction between excitatory and inhibitory synaptic influences on smooth muscles [J].
I. B. Filippov ;
I. A. Vladimirova ;
V. Ya. Ganitkevich ;
M. F. Shuba .
Neurophysiology, 2004, 36 :391-397
[15]   Adenylate Cyclase-Mediated Modulation of Interaction between Excitatory and Inhibitory Synaptic Influences on Smooth Muscles [J].
Filippov, I. B. ;
Vladimirova, I. A. ;
Ganitkevich, V. Ya. ;
Shuba, M. F. .
NEUROPHYSIOLOGY, 2004, 36 (5-6) :391-397
[16]   Enhanced cellular uptake of oligonucleotides by EGF receptor-mediated endocytosis in A549 cells [J].
Deshpande, D ;
ToledoVelasquez, D ;
Thakkar, D ;
Liang, WW ;
Rojanasakul, Y .
PHARMACEUTICAL RESEARCH, 1996, 13 (01) :57-61
[17]   EGF inhibits muscarinic receptor-mediated calcium signaling in a human salivary cell line [J].
Zhang, BX ;
Yeh, CK ;
Hymer, TK ;
Lifschitz, MD ;
Katz, MS .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 279 (04) :C1024-C1033
[18]   Lysophosphatidic acid (LPA) receptor-mediated signaling and cellular responses to anticancer drugs and radiation of cancer cells [J].
Ikeda, Hiroko ;
Takai, Miwa ;
Tsujiuchi, Toshifumi .
ADVANCES IN BIOLOGICAL REGULATION, 2024, 92
[19]   Ganglioside GM3 inhibition of EGF receptor mediated signal transduction [J].
Rebbaa, A ;
Hurh, J ;
Yamamoto, H ;
Kersey, DS ;
Bremer, EG .
GLYCOBIOLOGY, 1996, 6 (04) :399-406
[20]   RECEPTOR-MEDIATED SUPRAADDITIVE ACTIVATION OF GUINEA-PIG SUPERIOR CERVICAL-GANGLION ADENYLATE-CYCLASE - ROLE OF MN-2+ IONS AND CALMODULIN [J].
FERRETTI, ME ;
BORASIO, PG ;
BIONDI, C ;
CAMPI, AL ;
PARESCHI, MC ;
PORTOLAN, A .
NEUROCHEMICAL RESEARCH, 1991, 16 (05) :583-589